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Background: The process of discovering new drugs is a lengthy, time-consuming and expensive process.
Modern day drug discovery relies heavily on the rapid identification of novel ‘targets’, usually proteins that
can be modulated by small molecule drugs to cure or minimise the effects of a disease. Of the 20,000
proteins currently reported as comprising the human proteome, just under a quarter of these can potentially
be modulated by known small molecules Storing information in curated, actively maintained drug discovery
databases can help researchers access current drug discovery information quickly. However with the increase
in the amount of data generated from both experimental and in silico efforts, databases can become very large
very quickly and information retrieval from them can become a challenge. The development of database tools
that facilitate rapid information retrieval is important to keep up with the growth of databases.
Description: We have developed a Gene Ontology-based navigation tool (Gene Ontology Tree) to help users
retrieve biological information to single protein targets in the ChEMBL drug discovery database. 99 % of single
protein targets in ChEMBL have at least one GO annotation associated with them. There are 12,500 GO terms
associated to 6200 protein targets in the ChEMBL database resulting in a total of 140,000 annotations. The slim
we have created, the ‘ChEMBL protein target slim’ allows broad categorisation of the biology of 90 % of the
protein targets using just 300 high level, informative GO terms.
We used the GO slim method of assigning fewer higher level GO groupings to numerous very specific lower level
terms derived from the GOA to describe a set of GO terms relevant to proteins in ChEMBL. We then used the slim
created to provide a web based tool that allows a quick and easy navigation of protein target space. Terms from the
GO are used to capture information on protein molecular function, biological process and subcellular localisations.
The ChEMBL database also provides compound information for small molecules that have been tested for their
effects on these protein targets. The ‘ChEMBL protein target slim’ provides a means of firstly describing the biology
of protein drug targets and secondly allows users to easily establish a connection between biological and chemical
information regarding drugs and drug targets in ChEMBL.
The ‘ChEMBL protein target slim’ is available as a browsable ‘Gene Ontology Tree’ on the ChEMBL site under
the browse targets tab (https://www.ebi.ac.uk/chembl/target/browser). A ChEMBL protein target slim OBO file
containing the GO slim terms pertinent to ChEMBL is available from the GOC website (http://geneontology.
org/page/go-slim-and-subset-guide).
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Conclusions: We have created a protein target navigation tool based on the ‘ChEMBL protein target slim’.
The ‘ChEMBL protein target slim’ provides a way of browsing protein targets in ChEMBL using high level
GO terms that describe the molecular functions, processes and subcellular localisations of protein drug targets
in drug discovery. The tool also allows user to establish a link between ontological groupings representing
protein target biology to relevant compound information in ChEMBL. We have demonstrated by the use of
a simple example how the ‘ChEMBL protein target slim’ can be used to link biological processes with drug
information based on the information in the ChEMBL database. The tool has potential to aid in areas of
drug discovery such as drug repurposing studies or drug-disease-protein pathways.
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The use of small molecules in alleviating symptoms in a
disease state is generally evaluated against a protein tar-
get [1]. The human proteome is reported to have around
20,000 proteins [2] with literature sources reporting a great
variation in the number of proteins deemed to be druggable
[3, 4]. The biology of the druggable proteome (alternatively
the druggable genome) is usually described in terms of dis-
tinct and well-studied protein families. Protein family classi-
fication can be used together with protein-centric bio-
ontologies to better understand the characteristics of a drug
target of interest.
ChEMBL is a manually curated, freely available resource
containing bioactive ligands with drug-like properties as
well as quantitative bioassay results and the biological
targets of these molecules [5]. Biological targets reported
in ChEMBL assays include nucleic acids, cell-lines, tissues,
subcellular-fractions, whole organisms and proteins. Pro-
tein targets are the largest portion of targets in ChEMBL.
This target group is further divided into single protein
targets, protein complexes, protein families, and protein-
protein interactions. Compound information to ChEMBL
protein targets is obtained by manual curation of selected
published medicinal chemistry literature and data depo-
sitions from data sharing partnerships.
There has been a steady increase of data in ChEMBL
over time. There has been a fourfold increase in the
total numbers of assays from the first ChEMBL release
(ChEMBL1) to the current release (ChEMBL21) which
has 1.2 million assays. The number of single protein
targets doubled with the first release having 3222 single
protein targets to just over 6000 in the current release.
Standardising protein information in ChEMBL is useful to
facilitate ease of protein target retrieval. Single protein
targets in the database are cross-referenced to a variety of
protein property descriptors including Gene Ontology
(GO) based annotations. GO is a set of concepts, struc-
tured as a graph or tree, that provide a controlled and
concise way of capturing the processes, molecular func-
tions and subcellular localisations of gene products in thiscase proteins [6]. An annotation is an evidence-based as-
sertion created to capture biological information about a
protein [7]. GO annotations to protein targets in ChEMBL
are obtained from the GO consortium database [8]. These
annotations provide useful insight into the biology of
proteins in drug discovery. GO annotations vary in their
information content depending on the specificity of the
term used in annotation. Some annotations contain very
specific and fine-grained information about a protein
while others contain broad, high level information. Com-
paring, grouping or searching through protein targets
annotated at different levels of GO information content
can be time consuming and challenging. GO slims are
often used to allow comparison of protein information
captured at different levels of the GO.
A GO slim is a high-level subset of the GO created by
collapsing specific terms and ‘mapping’ them to their
higher level parent terms using the parent–child hierar-
chies inherent in the GO. GO slimming allows for a repre-
sentation of biological information by using high level
terms that provide a broad overview of the biology [8].
GO slims are typically generated for specific organism or
particular areas of scientific interest and have been used
to aid visualisation, exploration and summarization of
GO functional data [9, 10]. We have created a ‘ChEMBL
protein target slim’ to allow users to easily access the
biological information to targets with GO annotation.
Construction and content
Creating the ‘ChEMBL protein target slim’
We created the ChEMBL target slim by retrieving all rele-
vant annotations to single protein targets in ChEMBL
using the QuickGO tool [11]. QuickGO is a web browser
for GO terms and annotations. GO terms in QuickGO are
identified by an alpha numeric identifier, a term definition
and relationships established between a specific term and
other terms in GO. Annotations retrieved from QuickGO
are obtained from the Gene Ontology consortium GO
database and are created by consortium members. We
retrieved all annotations to the protein set across all
Table 1 Proteins mapped to GO slim terms per species






Escherichia coli K-12 74
Oryctolagus cuniculus 74
Mycobacterium tuberculosis 73
Saccharomyces cerevisiae S288c 70
Staphylococcus aureus 50
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Association File (GAF) which contains protein accessions
and GO term information.
We used the generic GO term mapper tool [12] to
identify an initial high level set of GO terms represen-
ting the annotation information for our protein target
set. The GO term mapper tool uses the map2slim algo-
rithm in ‘count mode’ to identify high level term parent
terms to terms in the annotation set. The slim terms
suggested by the algorithm are grouped according to the
number of proteins whose initial annotation has been
mapped to a higher level GO term. GO terms with a
high number of proteins mapped are incorporated in the
slim while terms with no proteins are removed. We
selected the Generic GO slim (version 1.2) as the refe-
rence slim for the selection of slim terms. This slim is
not species specific.
From the output the term mapping we manually
inspected and customised the slim to the ChEMBL pro-
tein target set as follows:
GO term refinement
We identified fine –grained annotations that could be
mapped to higher level terms. One of the considerations
made in this exercise was the information content of the
higher level terms. An example being proteins annotated
to granular protein binding terms like GO:0017124 SH3
domain binding were not mapped up to the higher level
parent GO:0005515 protein binding due to loss of infor-
mation content.
GO term selection
We assessed the number of accessions not mapped to
any term in the initial reference generic GO slim with a
view to customising the slim terms to reflect the biology
of the protein annotations in the set. We manually
added terms to the GO slim to address this.
We removed terms from the generic GO slim that did
not have any annotations in the ChEMBL protein set.
This addition, removal and term refinement was done
in several rounds of term-to-accession-mapped inspec-
tion until we obtained a set of slim terms providing a
good coverage (in this case 90 %) of the protein targets
in ChEMBL.
Results
The resultant ChEMBL protein target slim generated con-
tains a total of 300 high level GO terms representing the
biology of 5600 protein targets in ChEMBL in the three
areas of GO. In total, proteins from 532 different species
are mapped to terms in the GO slim. The top ten species
(in terms of number of proteins) in the current ChEMBL
release are shown in Table 1.Utility
Based on these slim term categories, we created a GO-
based navigation tool which is available on the ChEMBL
website. This tool termed the ‘Gene Ontology tree’ can
be found by clicking on the ‘Browse Targets’ tab on the
ChEMBL home page and selecting the radio button next
to the tree name.
The two key functionalities of the GO tree are:
a. Protein target browsing by GO categories
The ChEMBL protein target slim in the form of a
navigational GO tree also allows users to establish
which processes or functions proteins are involved
in by selecting the process and function nodes. The
cellular component node provides a quick overview
of the subcellular locations of protein targets as well
as a link out to small molecules interaction with
targets in a selected localisation (Fig. 1, Panel 1a).
The numbers affiliated with each GO category on
the tree allow a rapid assessment of which areas of
biology have high proteins giving an indication of
target prioritisation in drug discovery endeavours.
b. Searching for proteins and related compound
information
The tree has a search functionality that allows users
to search the database for protein information using
a specific biological key word or phrase to retrieve
all proteins targets annotated to that term as well
as the compounds and bioactivities to the selected
subset. Figure 1 shows how to use the tree to search
for all proteins involved in response to toxic
substance. By using a key phrase ‘toxic substance’ in
the search box, the GO slim allows retrieval of all
proteins annotated to GO:0009636 ‘response to toxic
substance’ (Fig. 1, Panel 1a). The tree shows 432
protein targets annotated to this term as well as
showing the more specific child terms of
GO:0009636 which are ‘GO:0046677 response to
antibiotic’. Right clicking on the GO term grouping
Fig. 1 Searching the ChEMBL database using the GO tree to retrieve all proteins involved in response to toxic substance and their related
compound and bioactivity information. Panel a shows the biological process node of the GO tree with a 'toxic substance' keyword search. Panel
b shows the search output of the list of proteins annotated with the 'toxic substance' GO term
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the protein targets annotated to that term as well
as the compounds tested against them and the
bioactivities reported for the assays (Fig. 1, panel
1b). A link exits to the QuickGO webpage to view
the definition of the GO term of interest.Case study- using Gene Ontology and drug ATC
information to further establish links between
biological and chemical space in ChEMBL
Another useful application of the biological groupings
created by the GO slim is the ability to provide insight
into the biology of a group of proteins that are targets of
drugs used for specific indications. The ChEMBL data
base contains information to small molecules important
in drug discovery. Small molecule to protein information
links are primarily established by considering the bio-
assay that the two entities are reported together in. In
addition, for FDA approved drugs, targets responsible
for their efficacy (mechanism of action) are assignedmanually. These high level drug classification categories
were combined with the higher level GO classification
categories for their targets to show the mechanism of
action information displayed in Fig. 3.
The database also uses World Health Organisation ana-
tomical therapeutic (ATC code) classifiers that describe
the mechanism of action of a drug to group drugs in
higher level categories. For examples drugs used against
parasitic infections are grouped as anti-protozoals with an
WHO ATC code of P01.
Figure 3 is a simple example of selecting a drug clas-
sification of interest from the ATC classification. We
retrieved all drugs from ChEMBL that are used as Anti-
neoplastic and Immunomodulating agents (WHO ATC
classification L [13]), and the curated mechanism of
action information and readily retrieving the biology of
the targets of these drugs by using the GO slim catego-
ries that describe their assigned efficacy targets.
The targets of all therapeutic drugs in release 20 of
ChEMBL consists of 1179 individual proteins. Of this
number, 196 proteins are targets of drugs in the ATC L
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biological processes that these proteins are involved in.
Figure 2 shows a venn diagram [14] of the 5 GO biological
process categories for these proteins as cell death, cell
motility, cell morphogenesis, cell proliferation and cell
death. The number of drugs that modulate the proteins in
each of the groupings are shown in the venn diagram sets.
It is immediately apparent that 24 drugs have targets rep-
resented in all 5 categories of biological grouping. Using
the drug mechanism of action information in ChEMBL
we probed this set of 24 drugs on mechanism and the two
main mechanism of actions shown are protein kinase
inhibitor action and growth factor receptor inhibition
(Fig. 3).
Considering higher level drug and target classification
can give broad insight into the biology for protein tar-
gets of drugs in the same classification.
Discussion
The existence of large numbers of protein annotations
in the GO database provides a useful resource for com-
putational querying of protein sets annotated in this
way. The fact that not all GO annotations are made to
the same level of term specificity can make it proble-
matic to query protein sets annotated with this way. GO
slims are a useful of compressing annotation information
to obtain a broad but informative overview of protein
biology. Grouping proteins into biological categories
using a GO slim approach comes with the caveat that
its is possible for a single protein to being represented
in more than one category due to the multi-functionalFig. 2 Number of drugs used as Antineoplastic and Immunomodulating A
generated using the ChEMBL slimnature of certain proteins. Similarly some proteins that
have yet to be annotated or protein whose annotations are
yet to be deposited in a database may not feature in such
grouping systems until such a time when the annotation is
created and incorporated in the database. The same can
be said of drug information. Some drugs have been known
to have protein targets from more than one biological
grouping due to the drug having multiple targets and/or
different mechanisms of action. However with the bio-
logical information captured using GO to protein targets
in ChEMBL, the GO slim still provides a quick and useful
way of navigating protein target space and related small
molecule information.
Conclusion
We have created a protein target navigational tool using
the ChEMBL protein target slim specifically designed
for browsing drug discovery protein targets. This tool
provides a rapid way of searching for biological informa-
tion to proteins in a large database. The tool also allows
for a rapid overview of the biology of protein target space.
Besides providing information on the biological process
and molecular functions of protein targets the navigation
tree also readily provides an overview of protein target
subcellular localisation.
The slim is freely available for use and is updated regu-
larly to reflect changes in both the GO and ChEMBL
protein target space. We anticipate the slim will be a use-
ful tool for other researchers and tool developers wishing
to display, explore and summarize GO data in the area of
drug discovery.gents (ATC Class L) targeting proteins in 5 biological process categories
Fig. 3 Mechanism of action for drugs at intersection of protein GO categories
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The ChEMBL drug target slim is freely available from the
ChEMBL website https://www.ebi.ac.uk/chembl/target/
browser [15]. The GO terms slim terms used for the slim
classes are available from the Gene Ontology Consortium
together with the other GO slims [16]. The ChEMBL data
is made available on a Creative Commons Attribution-
Share Alike 3.0 Unported License.
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